Patents by Inventor Nathalie Brassard

Nathalie Brassard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-LG3 antibodies and uses thereof
    Patent number: 8795974
    Abstract: A method for the prediction of the risk and/or the diagnosis of vascular damage such as acute vascular rejection in a subject, based on the determination of anti-LG3 antibodies levels in a sample from the subject, is disclosed.
    Type: Grant
    Filed: March 8, 2011
    Date of Patent: August 5, 2014
    Assignee: Val-Chum, Limited Partnership
    Inventors: Marie-Josee Hebert, Heloise Cardinal, Nathalie Brassard
  • ANTI-LG3 ANTIBODIES AND USES THEREOF
    Publication number: 20130004978
    Abstract: A method for the prediction of the risk and/or the diagnosis of vascular damage such as acute vascular rejection in a subject, based on the determination of anti-LG3 antibodies levels in a sample from the subject, is disclosed.
    Type: Application
    Filed: March 8, 2011
    Publication date: January 3, 2013
    Inventors: Marie-Josee Hebert, Heloise Cardinal, Nathalie Brassard
  • METHODS OR USE OF LAMIN B1 NUCLEAR ANTIGEN, FRAGMENTS AND COMPOSITIONS THEREOF, FOR INHIBITING OR REDUCING A THROMBOTIC EVENT
    Publication number: 20110009326
    Abstract: A method for preventing a thrombotic event in a patient susceptible to such an event, which comprises the step of administering an effective amount of a lamin 131 nuclear (LB1) antigen to said patient is provided along with an anti-thrombotic composition which comprises an effective amount of a lamin 131 nuclear (LB1) antigen and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: July 15, 2005
    Publication date: January 13, 2011
    Inventors: Yves Raymond, Jean-Luc Senecal, Marie-Soleil Christin-Piche, Nathalie Brassard